What is BridgeBio Pharma's compensation and benefits?

BridgeBio Pharma (BBIO) reported compensation and benefits of $39.34M in Q1 2026.

How has BridgeBio Pharma's compensation and benefits changed year-over-year?

BridgeBio Pharma's compensation and benefits increased by 17.6% year-over-year, from $33.45M to $39.34M.

What is the long-term trend for BridgeBio Pharma's compensation and benefits?

Over 5 years (2020 to 2025), BridgeBio Pharma's compensation and benefits has grown at a 20.9% compound annual growth rate (CAGR), from $29.68M to $76.7M.

BridgeBio Pharma BBIO Compensation and benefits

Compensation and benefits at other companies

PfizerPFE

——

Ionis PharmaceuticalsIONS

——

BioMarin PharmaceuticalsBMRN

——

Roivant SciencesROIV

——

Arrowhead ResearchARWR

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$194.5M+66.8%

Gross profit$184.6M+61.9%

Operating income-$106.0M-1.5%

Net income-$166.6M+1.8%

EPS (diluted)-$0.84+4.5%

Balance sheet

See full

Cash & equivalents$882.0M+62.5%

Total debt$3.3B+32,101%

Total equity-$2.3B-38.2%

Total assets$1.4B+55.5%

Cash flow

See full

Operating cash flow-$197.3M+1.0%

CapEx$69.0K—

Free cash flow-$197.3M+0.9%

Valuation

See full

Market cap$12.98B+119%

Enterprise value$15.36B+178%

P/S22.4×-24.1×

Profitability

See full

Gross margin95.1%-0.2pp

Operating margin-90.5%-41.2pp

Net margin-125.9%-54.5pp

FCF margin-76.8%—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity2×—

Current ratio1.5×-3.0×

Where this comes from

Reported directly by BridgeBio Pharma in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BridgeBio Pharma's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BridgeBio Pharma's compensation and benefits?: BridgeBio Pharma (BBIO) reported compensation and benefits of $39.34M in Q1 2026.
How has BridgeBio Pharma's compensation and benefits changed year-over-year?: BridgeBio Pharma's compensation and benefits increased by 17.6% year-over-year, from $33.45M to $39.34M.
What is the long-term trend for BridgeBio Pharma's compensation and benefits?: Over 5 years (2020 to 2025), BridgeBio Pharma's compensation and benefits has grown at a 20.9% compound annual growth rate (CAGR), from $29.68M to $76.7M.